Skip to main content

SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?

Publication ,  Journal Article
Heldman, MR; Limaye, AP
Published in: J Am Soc Nephrol
May 3, 2021

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Am Soc Nephrol

DOI

EISSN

1533-3450

Publication Date

May 3, 2021

Volume

32

Issue

5

Start / End Page

1021 / 1024

Location

United States

Related Subject Headings

  • Viral Load
  • Urology & Nephrology
  • Treatment Outcome
  • Transplantation Immunology
  • Transplant Recipients
  • Safety
  • SARS-CoV-2
  • Pandemics
  • Kidney Transplantation
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Heldman, M. R., & Limaye, A. P. (2021). SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? J Am Soc Nephrol, 32(5), 1021–1024. https://doi.org/10.1681/ASN.2021010023
Heldman, Madeleine R., and Ajit P. Limaye. “SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?J Am Soc Nephrol 32, no. 5 (May 3, 2021): 1021–24. https://doi.org/10.1681/ASN.2021010023.
Heldman, Madeleine R., and Ajit P. Limaye. “SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know?J Am Soc Nephrol, vol. 32, no. 5, May 2021, pp. 1021–24. Pubmed, doi:10.1681/ASN.2021010023.
Heldman MR, Limaye AP. SARS-CoV-2 Vaccines in Kidney Transplant Recipients: Will They Be Safe and Effective and How Will We Know? J Am Soc Nephrol. 2021 May 3;32(5):1021–1024.

Published In

J Am Soc Nephrol

DOI

EISSN

1533-3450

Publication Date

May 3, 2021

Volume

32

Issue

5

Start / End Page

1021 / 1024

Location

United States

Related Subject Headings

  • Viral Load
  • Urology & Nephrology
  • Treatment Outcome
  • Transplantation Immunology
  • Transplant Recipients
  • Safety
  • SARS-CoV-2
  • Pandemics
  • Kidney Transplantation
  • Humans